Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 26, 2012
Orthostatic hypotension, diabetes, and falling in older patients: a cross-sectional studyKornelis J J van Hateren, Nanne Kleefstra, Marco H Blanker, et al.
Diabetes Care|March 6, 2008
Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4)Nanne Kleefstra, Gijs W D Landman, Sebastiaan T Houweling, et al.
The European Journal of General Practice|March 23, 2017
Lifestyle and emotional well-being in men and women with type 2 diabetes (e-VitaDM-4; ZODIAC-48)Steven H Hendriks, Evelien G W van Soldt, Michael van Vugt, et al.
Diabetes Care|April 24, 2010
A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathyAlaa Alkhalaf, Astrid Klooster, Willem van Oeveren, et al.
Cancers|July 2, 2021
Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort StudyJing de Haan-Du, Gijs W D Landman, Nanne Kleefstra, et al.
American Heart Journal|March 21, 2016
High-sensitive troponin T is associated with all-cause and cardiovascular mortality in stable outpatients with type 2 diabetes (ZODIAC-37)Steven H Hendriks, Peter R van Dijk, Kornelis J J van Hateren, et al.
Plos One|July 29, 2015
Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)Kornelis J J van Hateren, Gijs W D Landman, Jarinke F H Arnold, et al.
Diabetes Care|June 13, 2013
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31)Ineke J Riphagen, Wendy E Boertien, Alaa Alkhalaf, et al.
Plos One|February 18, 2014
Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trialsGijs W D Landman, Geertruide H de Bock, Kornelis J J van Hateren, et al.
Diabetes Care|October 31, 2013
Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30)Gijs W D Landman, Peter R van Dijk, Iefke Drion, et al.
Pageof 12